Without a Ribbon
  • About
    • Events
    • Get In Touch
  • Rare Cancer Resources
  • Shop
  • How You Can Help
  • Meet Warriors
  • News
  • Login
  • Register

Select Page

HELP

LEARN

EVENTS

Myxoid Glioneuronal Tumour (MGT)

Become part of our growing rare cancer community.
Join our Facebook support group

Join Now

Posted by fatima.shakeel@opmc.co | May 12, 2026

What is Myxoid Glioneuronal Tumour?

Myxoid Glioneuronal Tumour (MGT) is a rare type of brain tumour that grows slowly. It is usually found near the ventricles, which are fluid-filled spaces inside the brain. This tumour is considered low-grade, meaning it is generally non-aggressive and often associated with a favourable outcome.

Causes

The exact cause of MGT is not fully understood. However, it is associated with a mutation in the PDGFRA gene, which plays a role in regulating cell growth. When this gene is altered, it can lead to abnormal cell growth and tumour formation. There is no evidence linking this tumour to lifestyle or environmental factors.

MGT is extremely rare, with only a limited number of cases reported worldwide. It is most commonly diagnosed in children and young adults and appears to affect males and females equally.

Signs and Symptoms

The symptoms of MGT depend largely on its location in the brain. Common symptoms may include:

  • Headaches
  • Seizures
  • Vomiting
  • Dizziness
  • Changes in behaviour or cognitive function
  • Visual disturbances

In some cases, the tumour may block the normal flow of cerebrospinal fluid, leading to increased pressure in the brain, which can worsen symptoms. Occasionally, the tumour may not cause any symptoms and is discovered incidentally during imaging for another condition.

Diagnosis

To confirm MGT, doctors take a step-by-step approach. First, they talk with you about your symptoms and do a basic examination. Then, an MRI scan is done to look inside the brain and identify the tumour. If needed, a small sample of the tumour is taken and examined in the lab to understand its structure. Doctors may also perform a genetic test to confirm the exact type of tumour.

Treatment

Surgical removal is the primary treatment for MGT. In most cases, surgery alone is sufficient, and patients experience excellent outcomes.

However, in rare situations:

  • The tumour may recur
  • Additional treatments, such as radiotherapy or chemotherapy, may be considered

Overall, MGT has a very good prognosis compared to many other brain tumours.


You can help us with your donation:

Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways:

Donations — Without a Ribbon is grateful when we receive every donation. Giving to Without a Ribbon helps us to provide ongoing support, organise the annual gathering and subsidise the costs of our Warriors attending these conferences.
Sponsorship — If you wish to sponsor our charity, please contact us using this form.
Volunteering — We are always looking for volunteers to help with different aspects of running our charity. So, if you are looking for volunteer work, please feel free to contact us.

Share:

PreviousOur New Resource Page for High-Grade Astrocytoma with Piloid Features
NextOur New Resource Page for Myxoid Glioneuronal Tumour (MGT)

If you need any help or advice just

Get In Touch

© Without a Ribbon 2019. All rights reserved.Powered by WEB 105 Creative

Stay up to date.

Sign up to our newsletter